The extracted data underscore that the somatic mutations in ACTB and ACTG1 do not occur haphazardly across cancers and that the higher frequency observed in two skin cancer and two DLBCL studies merits further investigation. The gene discussed is ACTG1; the disease is diffuse large B-cell lymphoma.